Search research articles
Contact Us
Filters
Showing results (321-330 of 367) with videos related to
Page
of 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2008
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial
Mitch Dowsett, Craig Allred, Jill Knox, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 15, 2012
Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention
D Gareth R Evans, Jane Warwick, Susan M Astley, et al.
The Lancet. Oncology
|
January 22, 2010
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
Breast Cancer Research : BCR
|
February 7, 2018
A comparison of five methods of measuring mammographic density: a case-control study
Susan M Astley, Elaine F Harkness, Jamie C Sergeant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction
Kala Visvanathan, Rowan T Chlebowski, Patricia Hurley, et al.
International Journal of Cancer
|
July 27, 2010
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively
M Frank O'Brien, Angel M Cronin, Paul A Fearn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2013
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence
Michael D Allen, Gareth J Thomas, Sarah Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline
Kala Visvanathan, Patricia Hurley, Elissa Bantug, et al.
Archives of Pathology & Laboratory Medicine
|
November 14, 2019
Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology
Philip E Castle, Rachael Adcock, Jack Cuzick, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 12, 2017
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
John M S Bartlett, Ikhlaaq Ahmed, Meredith M Regan, et al.
Page
of 37
Search research articles
Search
Showing results (321-330 of 367) with videos related to
Sort By:
Page
of 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2008
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial
Mitch Dowsett, Craig Allred, Jill Knox, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
May 15, 2012
Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention
D Gareth R Evans, Jane Warwick, Susan M Astley, et al.
The Lancet. Oncology
|
January 22, 2010
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
Breast Cancer Research : BCR
|
February 7, 2018
A comparison of five methods of measuring mammographic density: a case-control study
Susan M Astley, Elaine F Harkness, Jamie C Sergeant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction
Kala Visvanathan, Rowan T Chlebowski, Patricia Hurley, et al.
International Journal of Cancer
|
July 27, 2010
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively
M Frank O'Brien, Angel M Cronin, Paul A Fearn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2013
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence
Michael D Allen, Gareth J Thomas, Sarah Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline
Kala Visvanathan, Patricia Hurley, Elissa Bantug, et al.
Archives of Pathology & Laboratory Medicine
|
November 14, 2019
Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology
Philip E Castle, Rachael Adcock, Jack Cuzick, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 12, 2017
HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
John M S Bartlett, Ikhlaaq Ahmed, Meredith M Regan, et al.
Page
of 37